Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-24

Clinical Trial Update: Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated daily co-trimoxazole prophylaxis for preventing malaria in pregnancy, including HIV-infected women. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Co-trimoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Malaria in Pregnancy, HIV Infections | Phase 3 | Status: COMPLETED